Share

Biontech gets go-ahead to start Covid-19 vaccine trial

Shares of Biontech were higher today after the company was approved to start its Covid-19 clincial vaccine trial in Germany. CNBC's Meg Tirrell reports.
02:13
Wed, Apr 22 20203:34 PM EDT